Talphera Inc. is a pharmaceutical company focused on the development and commercialization of therapies for use in medically supervised settings. The Company's nafamostat product candidates include Niyad and LTX-608. Its portfolio consists of nafamostat product candidates and pre-filled syringe product candidates.

What symbol and exchange does Talphera shares trade?

Talphera trades on the NASDAQ stock market under the symbol TLPH.

What is Talphera stock price doing today?

As of October 22, 2026, TLPH stock price declined to $1.05 with 35,936 million shares trading.

What is Talphera's Beta?

TLPH has a beta of 1.36, meaning it tends to be more sensitive to market movements. TLPH has a correlation of 0.06 to the broad based SPY ETF.

How much is Talphera worth?

TLPH has a market cap of $54.49 million. This is considered a Micro Cap stock.

What are the top ETFs holding Talphera?

The top ETF exchange traded funds that TLPH belongs to (by Net Assets): VXF, VTI.

Is Talphera (TLPH) a good investment?

TLPH has underperformed the market in the last year with a return of -7.1%, while the SPY ETF gained +14.9%. In the last 3 month period, TLPH fell short of the market, returning -19.8%, while SPY returned +2.3%. However, in the most recent 2 weeks TLPH has outperformed the stock market by returning 0.0%, while SPY returned -1.7%.

What are the support and resistance levels for Talphera (TLPH)?

TLPH support price is $1.04 and resistance is $1.11 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that TLPH shares will trade within this expected range on the day.